MMP9 and Stroke: In regards to long-term outcomes, MMP-9 was associated with a poor neurological outcome at 3 months post-stroke (Rodríguez-Yáñez et al., 2006) and hyperacute levels of MMP-9 correlated with worse Rankin outcome at 3 months post-stroke (Ning et al., 2006).